NL143812B - Piperidinederivaten met inhibitorwerking op het centrale zenuwstelsel, alsmede gevormde geneesmiddelen die deze derivaten bevatten. - Google Patents

Piperidinederivaten met inhibitorwerking op het centrale zenuwstelsel, alsmede gevormde geneesmiddelen die deze derivaten bevatten.

Info

Publication number
NL143812B
NL143812B NL61271658A NL271658A NL143812B NL 143812 B NL143812 B NL 143812B NL 61271658 A NL61271658 A NL 61271658A NL 271658 A NL271658 A NL 271658A NL 143812 B NL143812 B NL 143812B
Authority
NL
Netherlands
Prior art keywords
derivatives
nervous system
central nervous
products containing
medicinal products
Prior art date
Application number
NL61271658A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NL143812B publication Critical patent/NL143812B/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
NL61271658A 1960-12-01 1961-11-22 Piperidinederivaten met inhibitorwerking op het centrale zenuwstelsel, alsmede gevormde geneesmiddelen die deze derivaten bevatten. NL143812B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72855A US3041344A (en) 1960-12-01 1960-12-01 1-(aroylalkyl)-4-piperidinecarboxamides

Publications (1)

Publication Number Publication Date
NL143812B true NL143812B (nl) 1974-11-15

Family

ID=22110159

Family Applications (2)

Application Number Title Priority Date Filing Date
NL271658D NL271658A (nl) 1960-12-01
NL61271658A NL143812B (nl) 1960-12-01 1961-11-22 Piperidinederivaten met inhibitorwerking op het centrale zenuwstelsel, alsmede gevormde geneesmiddelen die deze derivaten bevatten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL271658D NL271658A (nl) 1960-12-01

Country Status (8)

Country Link
US (1) US3041344A (nl)
BE (1) BE610830A (nl)
BR (1) BR6134582D0 (nl)
CH (1) CH428733A (nl)
DK (1) DK104787C (nl)
FR (1) FR1604106A (nl)
GB (1) GB940599A (nl)
NL (2) NL143812B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125574A (en) * 1964-03-17 I-aroylpropylx-acyl-x-amino-
US3308130A (en) * 1962-04-26 1967-03-07 Du Pont N-disubstituted carbamyl pyrazoles
US3330836A (en) * 1964-03-24 1967-07-11 Sandoz Ag 4-amino-isonipecotic acid
BE791678A (fr) * 1971-11-23 1973-05-21 Labaz Nouveaux derives de decahydroquinoleinol, leur procede de preparation ainsi que les compositions therapeutiques les contenant
US4009173A (en) * 1972-06-12 1977-02-22 Sumitomo Chemical Company, Limited Butyrophenone derivatives
DE4138756A1 (de) * 1991-11-26 1993-05-27 Troponwerke Gmbh & Co Kg Kombination mit neuroprotektiver wirkung
RU2230740C2 (ru) * 1998-03-31 2004-06-20 Акадиа Фармасьютикалз, Инк. Производные азотсодержащих гетероциклических соединений и фармацевтическая композиция на их основе
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
DE10153346A1 (de) * 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
WO2014156196A1 (ja) * 2013-03-29 2014-10-02 一般社団法人ファルマバレープロジェクト支援機構 ２型糖尿病治療剤
US10633336B2 (en) 2014-12-19 2020-04-28 The Broad Institute, Inc. Dopamine D2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands
US10339192B1 (en) 2017-11-30 2019-07-02 Growpath, Inc. Systems and methods for matching buzzwords in a client management system

Also Published As

Publication number Publication date
GB940599A (en) 1963-10-30
US3041344A (en) 1962-06-26
NL271658A (nl)
DK104787C (da) 1966-07-04
FR1604106A (en) 1971-07-12
BR6134582D0 (pt) 1973-05-24
BE610830A (nl)
CH428733A (de) 1967-01-31

Similar Documents

Publication Publication Date Title
FR1658M (fr) Nouveaux produits anorexigenes et euphoriques.
NL143812B (nl) Piperidinederivaten met inhibitorwerking op het centrale zenuwstelsel, alsmede gevormde geneesmiddelen die deze derivaten bevatten.
FR1426M (fr) 2-alcoyl-3-allylthiométhyl-7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4,-diazines substituées en position 6.
AT276444B (de) Kraftangetriebene Schreibmaschine od.dgl.
BE609796A (fr) perfectionnée.
AT247382B (de) Schreibmaschine od. dgl.
FI45380C (fi) Ristiuraruuvi.
AT238535B (de) Spannfutter od. dgl.
FR1073M (fr) Médicament sédatif de la série des thiaxanthenes.
FR1453M (fr) Médicament analgéique, antithermique, antirhumatismal.
FR1013M (fr) Médicament analgésique, antithermique et antirhumatismal.
FR1080M (fr) Médicament a base de griséofulvine.
FR113M (fr) Produit myorésolutif, analgésique et sédatif.
FR1075M (fr) Médicament a base de 4-nitro-3-hydroxy-thiofene-2-carboxylate de méthyle.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.
FR1099M (fr) Médicament gastro-entérologique.
FR1765M (fr) Médicament anticryptogamique.
GR21887B (el) Μονοζυγον μπαρα.
BE604097A (fr) Médicament dilatateur des coronaires.
GR21244B (el) Διχρωμα πλαστικα αντικειμενα εκ πολυαιθυλινης.
ES1008804Y (es) Estructura perfeccionada para estanterias iluminables.
FR1441M (fr) Médicament gastro-hépato-entérologique.
FR1337M (fr) Médicament antihypokaliémique.
FR1515M (fr) Médicament eutrophique.
FR1498M (fr) Médicament a base de dérivé de la pyrido-benzothiazine.

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: JANSSEN

V4 Discontinued because of reaching the maximum lifetime of a patent